fda warning bpc 157 compounded peptide not approved mulls compounding for peptides previously flagged over safety risks EVEXIAS Life Sciences filing lawsuit
Description
The peptide may prove most valuable as an adjunct to post-surgical rehabilitation or for managing small, stable tears conservatively
After reconstitution with BAC water, refrigerate at 28C and use within 812 weeks
One test cannot determine the cause
Nausea (most common, especially during first 1 to 2 weeks of a new dose) Diarrhea or, just as often, constipation Vomiting (less common but more likely at 9 to 12 mg) Reduced appetite, food noise quieting down (this is the goal, not a side effect) Skin sensitivity (dysesthesia): tingling, prickly feeling, or sunburn-like skin
Insurance coverage varies
